[Primary percutaneous coronary angioplasty in patients with acute coronary syndrome and concomitant cancer].

The paper gives the results of X-ray surgical treatment in patients with acute coronary syndrome who have been ascertained to have concomitant cancer during their examination. Cancer was found in 11 patients in their medical history and diagnosed in 2 patients during examination after surgical treatment and 1 patient one year after his hospital discharge. The results of combination treatment showed the high efficiency of X-ray surgical treatment for acute coronary syndrome. Recovery of TIMI-III blood flow through the infarct-related coronary artery was achieved in 100% of cases; immediate clinical efficiency was 97.4%. In the concomitant cancer group, the therapeutic efficacy was 100%; there were no complications during X-ray surgery. All the patients from this group were discharged from hospital in a satisfactory state to be followed up by a cardiologist and oncologist for further treatment. The study performed suggests that concomitant cancer is not a contraindication to primary coronary angioplasty in patients with acute coronary syndrome. Primary coronary angioplasty with stenting is a safe effective treatment for acute coronary syndrome in this category of patients.
AuthorsR S Goloshchapov-Aksenov, A V Lebedev, V A Mirzonov
JournalVestnik rentgenologii i radiologii (Vestn Rentgenol Radiol) 2012 Jan-Feb Issue 1 Pg. 17-20 ISSN: 0042-4676 [Print] Russia (Federation)
PMID22679809 (Publication Type: English Abstract, Journal Article)
  • Acute Coronary Syndrome (complications, surgery)
  • Aged
  • Angioplasty, Balloon, Coronary (methods)
  • Female
  • Humans
  • Male
  • Middle Aged
  • Neoplasms (complications)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: